Chronic active thrombotic microangiopathy in native and transplanted kidneys

Annals of Clinical and Laboratory Science

Volumn 36, Issue 3, 2006, Pages 319-325

  Zhang, Ping L ^a   Prichard, Jeffery W ^a   Lin, Fan ^a   Shultz, Michael F ^a   Malek, Sayeed K ^a   Shaw IV, John H ^b   Hartle, James E ^a  

^a GEISINGER MEDICAL CENTER   (United States)

^b WEIS CENTER FOR RESEARCH   (United States)

Author keywords

Anti phospholipid antibody syndrome; Preeclampsia; Renal transplantation; Thrombocytopenia; Thrombotic microangiopathy

Indexed keywords

DNA ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CHRONIC DISEASE; ENCEPHALITIS; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; POSTOPERATIVE COMPLICATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CHRONIC DISEASE; FEMALE; GLOMERULAR BASEMENT MEMBRANE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MICROCIRCULATION; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOCYTOPENIA; THROMBOSIS;

EID: 33748268345     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. D'Agati VD, Jennette JC, Silva FG. Non-neoplastic kidney diseases. In: Altas of Nontumor Pathology, First Series, Fascicle 4, Chapter 18, Armed Forces Institute of Pathology, Washington, DC, 2005; pp 481-516.
2. Remmuzzi G, Ruggenenti P, Bertani T. Thrombotic microangiopathy. In: Renal Pathology with Clinical and Functional Correlations, 2nd ed (Tisher CC, Brenner BM, Eds), Lippincott-Raven, Philadelphia, 1994; pp 1154-1184.
3. Gaber LW, Spargo BH, Lindheimer MD. The nephropathy of preeclampsia-eclampsia. In: Renal Pathology with Clinical and Functional Correlations, 2nd ed (Tisher CC, Brenner BM, Eds), Lippincott-Raven, Philadelphia, 1994; pp 419-441.
4. Laszik Z, Silva FG. Hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura, and systemic sclerosis (systemic scleroderma). In: Heptinstall's Pathology of the Kidney, 5th ed (Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds), Lippincott-Raven, Philadelphia, 1998; pp 1003-1058.
5. Fogo AB. Renal disease in pregnancy. In: Heptinstall's Pathology of the Kidney, 5th ed (Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds), Lippincott-Raven, Philadelphia, 1998; pp 1097-1130.
6. Spargo BH, McCartney CP, Winemiller R. Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol 1959;68:593-599.
7. Hsu HC, Suzuki Y, Churg J, Grishman E. Ultrastructure of transplant glomerulopathy. Histopathology 1980;4: 351-367.
8. Hebert D, Kim EM, Sibley RK, Mauer MS. Post-transplantation outcome of patients with hemolytic-uremic syndrome: update. Pediatr Nephrol 1991;5:162-167.
9. Eijgenraan FJ, Donckerwolcke RA, Monnens LA, Proesmans W, Wolff ED, von Damme B. Renal transplantation in 20 children with hemolytic-uremic syndrome. Clin Nephrol 1990;33:87.
10. Knechtle SJ, Fernandez LA, Pirsch JD, et al. Campath-1H in renal transplantation: the University of Wisconsin experience. Surgery 2004;136:754:760.
11. Ciancio G, Burke GW, Gaynor JJ, et al. The use of Campath-1H as induction therapy in renal transplant: preliminary results. Transplantation 2004;78:426-433.
12. Zhang PL, Malek SK, Prichard JW, et al. Acute renal rejection predominated by monocytes is a severe form of rejection in human recipients with or without Campath-1H (Alemtuzumab) induction therapy. Am J Transplant 2005;5:604-607.
13. Calne RY. Prope tolerance: the future of organ transplantation-from the laboratory to the clinic. Transplantation 2004;77:930-932.